joimax® Obtains Full Product Registration in Thailand, and is Now Active in...
IRVINE, Calif. joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding...
View Article新研究评估Masimo PVi®监测在结直肠手术中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布近期一项在低危结直肠手术患者中开展的研究的结果,研究人员在该研究中评估Masimo PVi®(脉搏灌注变异指数)无创连续监测在指导补液管控中的功用,并与创伤性的监测方法食管多普勒相比较。研究人员未发现这两种技术的平均总补液量有显著差异,因此断言,“PVi可为该组患者目的为导向治疗提供完全无创替代方法。1”...
View ArticleAvita Medical Named to 2017 OTCQX Best 50
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleEFIL Center Is Attracting Overseas Patients to Its Exophthalmos Center, Korea
DAEGU, South Korea JCI(Joint Commission International)-accredited EFIL Plastic Surgery is drawing attention across the globe with its exophthalmos surgery. This Smart News Release features...
View Article大腸手術中におけるMasimo PVi®モニタリングの有用性を評価する新研究
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ (NASDAQ: MASI)は本日、大腸手術を受ける低リスク患者を対象に最近実施された研究の結果を発表しました。研究で研究者らは、侵襲的手段である経食道ドップラーとの比較で、輸液管理の指針としての非侵襲的・連続的Masimo...
View ArticleAvita Medical Announces Last Patient Visit in U.S. Pivotal Trial
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleSpinalCyte的里程碑式试验完成首例成纤维细胞注射以促使椎间盘再生
休斯敦 (美国商业资讯) — SpinalCyte, LLC是一家总部位于美国德州的组织工程技术公司,专注于采用人类皮肤成纤维细胞进行椎间盘髓核的再生。该公司今天宣布,已完成首例成纤维细胞注射以促使椎间盘再生。CybroCell是首个用于治疗退行性椎间盘疾病的皮肤成纤维细胞产品。该手术采用局部麻醉,在15分钟以内完成。患者未出现并发症,在1小时内出院。 SpinalCyte首席执行官Pete...
View ArticleSpinalCyteの画期的な椎間板再生試験で初の線維芽細胞注入が実施される
ヒューストン (ビジネスワイヤ) — テキサスに拠点を置き、ヒト皮膚線維芽細胞を使用した椎間板髄核の再生に傾注する組織工学技術企業のSpinalCyte,...
View ArticleBioventus投资于EXOGEN®的新临床研究
北卡罗莱纳州达勒姆 (美国商业资讯) — 全球性骨愈合解决方案领先者Bioventus今天宣布,将开展一个创新系列的真实世界证据、直接至患者研究,以进一步验证其EXOGEN超声波骨愈合系统在存在已知风险因素时能否降低骨折进展为骨折不愈合的风险。EXOGEN于1994年获得FDA...
View ArticleBioventusがEXOGEN®の新しい臨床研究に投資
米ノースカロライナ州ダーラム (ビジネスワイヤ) — オーソバイオロジクスの世界的リーダー企業のBioventusは本日、既知のリスク要因の存在下で骨折が癒合不全へと進行するリスクを軽減する当社製EXOGEN(エクソジェン)超音波骨折治療システムの能力をさらに検証するため、革新的シリーズのリアルワールドエビデンス対患者直接試験を委託すると発表しました。FDA...
View ArticleDr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and...
HYDERABAD, India Dr. Reddy’s Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
View ArticleCardiovascular Systems, Inc. Receives Approval for the Diamondback 360®...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the Diamondback 360 Coronary OAS Micro Crown as a...
View ArticleCorindus Announces First Robotic-Assisted PCI Procedures Performed in Asia...
WALTHAM, Mass. Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, announced today that the first robotic-assisted PCI procedures were performed in...
View ArticleLombard Medical and MicroPort Scientific Corporation Finalize Strategic...
OXFORDSHIRE, U.K. & SHANGHAI Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading...
View ArticleCorindus宣布,首批采用CorPath® GRX系统的机器人PCI辅助手术在亚洲完成
马萨诸塞州沃尔瑟姆 — (美国商业资讯) — 精准血管机器人的领先开发者Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS)今天宣布,首批采用其CorPath GRX系统的机器人辅助PCI手术在亚洲完成。上述手术之一由阜外医院向中国介入治疗会议的8000多位与会者实况转播。今年在中国北京召开的此次年会是亚太区最大的介入心内科会议。...
View ArticleAcelity Names R. Andrew Eckert President and Chief Executive Officer
SAN ANTONIO Acelity L.P. Inc., a leading global advanced wound care company, today announced that it has named R. Andrew Eckert as President and Chief Executive Officer. Eckert succeeds Joseph...
View ArticleU.S. FDA Approves Increased Compassionate Use Patient Cases and Sites for...
VALENCIA, Calif. & PERTH, Australia & LONDON The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the...
View Articlejoimax® Celebrates Its 10th Anniversary with 900 Users in China and Reports a...
IRVINE, Calif. joimax®, the German-based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, recently celebrated its 10-year anniversary in China...
View ArticlePSMF邀请国际患者安全界参加2017年7月13日召开的该基金会第5届年中规划年会
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)邀请来自全世界的患者安全专家、医护提供者、医院管理者、患者维权人士和政策制订者,来讨论挑战、头脑风暴解决方案和规划下一步,以达到在2020年之前将可预防死亡例数降至零的目标。与上次年中规划会议一样,本次会议主要是一次工作会议,旨在确定明年的目标。本次会议仅接受受邀者参加,将与Inova心血管研究所共同举办,地点在弗吉尼亚州Falls...
View Article